SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Earnings
Amgen Touts Q2 Growth Bolstered by Horizon Buy, Promising Obesity Pipeline
The company is projecting that future growth will be driven by geographic and label expansions for its rare disease assets, as well as potential approvals in obesity.
August 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company
Vaccines
Gardasil Chinese Distribution Issue Still a Mystery to Analysts
After Merck noted the issue in its Q2 earnings call without providing specifics, analysts are left in the dark about the HPV vaccine’s future in China.
August 7, 2024
 · 
3 min read
 · 
Tyler Patchen
Donkey and elephant with money
Policy
As Election Nears, Pharma Hedges Campaign Contribution Bets
Lobbying groups and individuals connected with the industry are supporting candidates from both parties, with a particular focus on the future of the 340B discount program and pharmacy benefit managers.
August 7, 2024
 · 
4 min read
 · 
Tyler Patchen
DNA and single-use syringes
Rare Diseases
Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines
Experts say the time is now to develop and provide widespread access to genetic medicines for the rarest diseases. What’s more, they say it is a moral imperative.
August 7, 2024
 · 
6 min read
 · 
Heather McKenzie
Podcast
Pharma Campaign Contributions, Vaccine Hiccups and Lykos’ Moment of Truth
With U.S. election season now in full swing, BioSpace looks at pharmaceutical-associated campaign contributions. Plus, Q2 earnings, Adaptimmune’s big approval, an anticipated FDA decision on an MDMA-assisted treatment and more.
August 7, 2024
 · 
1 min read
 · 
Heather McKenzie
exteriors of Merck, Biogen and BMS
Deals
Top I&I Deals So Far in 2024
The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.
August 7, 2024
 · 
5 min read
 · 
Mollie Barnes
Drug Development
Positioning QARA as a Market Access Function in Globalization
In this live panel discussion, speakers focused on the EU AI Act’s global regulatory implications for medical devices & QARA’s future. An executive summary is available.
August 6, 2024
 · 
1 min read
 · 
Lori Ellis
Drug Development
The Benefits of a Connected Quality & Regulatory Ecosystem
In this live panel discussion, speakers navigate integrated ecosystems and the future of QARA. An executive summary is available.
August 6, 2024
 · 
1 min read
 · 
Lori Ellis
Drug Development
Applying AI in Today’s Reality of QARA Processes
In this live panel discussion, speakers explore artificial intelligence in medtech and practical realities in QARA. An executive summary is available.
August 6, 2024
 · 
1 min read
 · 
Lori Ellis
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS